Trial Profile
Combined Effect of CFTR Modifiers and Intensive Antibiotic Treatment
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Ceftazidime (Primary) ; Ciprofloxacin (Primary) ; Ciprofloxacin (Primary) ; Colistin (Primary) ; Colistin (Primary) ; Flucloxacillin (Primary) ; Ivacaftor (Primary) ; Meropenem (Primary) ; Tobramycin (Primary) ; Tobramycin (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 13 Sep 2016 New trial record